Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DNA damage enhancement via radiation-induced effects refers to strategies that increase the extent or persistence of DNA lesions caused by ionizing radiation, primarily in cancer cells. This involves inhibiting cellular defense mechanisms such as DNA repair pathways (NHEJ, HR, BER, NER) and cell cycle checkpoints, or activating immune responses via cGAS-STING. The goal is to maximize tumor cell death while minimizing harm to normal tissues. Agents like PARP inhibitors, ATM/ATR inhibitors, and topoisomerase inhibitors are used in combination with radiotherapy to achieve this.
Inhibition of DNA repair pathways (NHEJ, HR, BER, NER), checkpoint inhibition, activation of cGAS-STING pathway
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DNA Damage Enhancement via Radiation-Induced Effects (DDE-RIE).